A nurse administers nonopioid analgesics and adjuvant
analgesics to a patient who has chronic cancer pain. Which step
of the World Health Organization (WHO) analgesic ladder
would include this drug administration?
1
Step 1
2
Step 2
3
Step 3
4
Step 4 Correct Answers 1
The WHO analgesic ladder is a recommended approach for the
management of cancer pain. The first step of pain management
using the WHO analgesic ladder is the use of nonopioid
analgesics and adjuvants. The second step of pain management
using the WHO analgesic ladder is the use of weak opioid
analgesics along with nonopioids. The third step of pain
management using the WHO analgesic ladder is the use of
strong opioid analgesics, such as morphine. The fourth step of
pain management using the WHO analgesic ladder is the use of
a multimodel approach for pain management.
The nurse is evaluating the statements made by the nursing
student about pain. Which statement by the nursing student is
true?
1
"Psychogenic pain is not real."
, 2
"Drug abusers overreact to pain."
3
"Intensity of the pain does not accurately indicate the tissue
damage."
4
"Patients with minor illness have less pain than patients with
major trauma." Correct Answers 3
The statement, "Intensity of the pain does not accurately indicate
the tissue damage" is true. There are many misconceptions about
pain, such as that psychogenic pain is not real, drug abusers
overreact to pain, and patients with minor illnesses have less
pain than patients with major trauma.
The nurse is initiating patient-controlled analgesia (PCA) per the
health care provider's prescription to the patient who has
myalgia. The nurse inserts the needleless adapter at the Y-site of
the intravenous tubing. Which statement describes the purpose
of this nursing action?
1
The risk of infection is reduced.
2
An unimpeded flow of infusion is ensured.
3
The entry of air from infusing into the intravenous (IV) line is
prevented.
4
The route for medication administration into the IV line is
established. Correct Answers 4
Inserting the needleless adapter at the Y-site of the peripheral IV
site establishes medication entry into the main IV line. Wiping